OpenAI and Microsoft Corp. are revising the terms of their partnership that will enable the ChatGPT maker to go public at a future date while preserving the software giant’s access to artificial ...

Software giant Microsoft and artificial intelligence firm OpenAI have reportedly entered talks to renegotiate their ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The AI moved the cake (which had been barely visible behind the paper towel roll in the original still) to be the focal point ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Google's antitrust trial, like Microsoft's, may have inadvertently spurred innovation by competitors, challenging its search ...

SoftBank Group Corp.’s plans to invest $100 billion in artificial intelligence infrastructure in the US have slowed, with ...

Their latest public exchange unfolded on Saturday on X, sparked by a political flashpoint involving U.S. President Donald ...

The ongoing discussions could transform OpenAI's setup, shifting it from its original nonprofit research focus to a mixed ...

Today, we’re all making strides forward at the same time. This presents an opportunity not just for us, but for everyone.

As the president heads to the Middle East, America’s dominance over A.I. chips has become a powerful source of leverage for the president.

Tech giants plan to use their Trump-era lobbying muscle to head off state AI regulations. But can they agree on what they ...